13-Aug-2026
Download PDF
Sudarshan Pharma
The Company has entered into a Memorandum of Understanding to acquire 1 24 64 000 equity shares of Rs.10/- each of the target company (76% of paid up equity share capital). The acquisition includes acquisition of business manufacturing plant and the team subject to due diligence and other regulatory approvals. Upon completion of the acquistion the target company would become a subsidiary of the Company.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
